In a recent study published in Nature Immunology, researchers investigated whether stem-like T lymphocytes are involved in ulcerative colitis (UC) pathogenesis. UC is an inflammatory illness ...

Considerable incremental progress is being made towards understanding the etiopathogenesis and improving the diagnosis of ulcerative colitis. At this juncture, however, we do not have good ...

Real-world data show distinct determinants of health-related quality of life in Crohn’s disease and ulcerative colitis, ...

Tumor necrosis factor-α (TNF-α) is a key cytokine involved in the pathogenesis of ulcerative colitis (UC), a chronic inflammatory bowel disease, and has emerged as a promising therapeutic target.

Switching to a second-line Janus kinase (JAK) inhibitor resulted in steroid-free clinical remission in about half of the patients with active ulcerative colitis (UC) after induction; compared with ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...